Evidence map›Paper›PMID 36943645›Full record

ArticleJournal of computer-aided molecular design2023

Improvement of multi-task learning by data enrichment: application for drug discovery.

Ekaterina A Sosnina, Sergey Sosnin, Maxim V Fedorov

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Comparing massively-multitask regression algorithms for drug discovery.Journal of computer-aided molecular design · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ekaterina A SosninaCenter for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30/1, Moscow, Russia, 143026. ekaterina.sosnina@skoltech.ru.
Sergey Sosnin *Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1190, Vienna, Austria.
Maxim V Fedorov *Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30/1, Moscow, Russia, 143026.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-task learning in deep neural networks has become a topic of growing importance in many research fields, including drug discovery. However, applying multi-task learning poses new challenges in improving prediction performance. This study investigated the potential of training data enrichment to enhance multi-task model prediction quality in drug discovery. The study evaluated four scenarios with varying degrees of information capacity of the training data and applied two types of test data to evaluate prediction performance. We used three datasets: ViralChEMBL, which consisted of binary activities of compounds against viral species, was applied for the classification task; pQSAR(159) and pQSAR(4267), which consisted of bio-activities of compounds and assays from the research of the profile-QSAR method, were applied for regression tasks. We built multi-task models based on the feed-forward DNNs using the PyTorch framework. Our findings showed that training data enrichment could be an effective means of enhancing prediction performance in multi-task learning, but the degree of improvement depends on the quality of the training data. The more unique compounds and targets the training data included, the more new compound-target interactions are required for prediction improvement. Also, we found out that even using multi-task learning, one could not predict the interactions of compounds that are highly dissimilar from those used for model training. The study provides some recommendations for effectively employing multi-task learning in drug discovery to improve prediction accuracy and facilitate the discovery of novel drug candidates.

Indexed as

Drug DiscoveryNeural Networks, ComputerApplicability domainData enrichmentDeep neural networkMulti-task predictionRecommender systems

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.